Overview
An antibody screen incubates patient plasma/serum with two or three reagent red cells expressing major clinically significant antigens and reads for agglutination/hemolysis, typically at AHG phase.
Clinical Importance
Detect unexpected alloantibodies before transfusion
Prenatal alloantibody detection
Specimen Requirements
- Specimen: whole blood (EDTA preferred for most typing, screens, and crossmatches)
- Tube: lavender/pink-top K₂EDTA (follow institutional blood bank tube color policy)
- Identity: two unique patient identifiers; many sites require a witnessed/type-and-screen collection process
- Handling: mix gently; do not use grossly hemolyzed specimens for serologic interpretation without investigation
- Timing: specimen age limits for pretransfusion testing are SOP-/standards-defined (commonly ≤3 days for patients who may have been transfused or pregnant recently; verify local AABB-aligned policy)
Analytical Method
Screening cells of known phenotypes are tested by tube (LISS/PEG), gel, or solid-phase IAT methods. A positive screen triggers antibody identification. Enhancement media and anti-IgG (± C3) AHG vary by method.
Instruments Used
Automated analyzers
- Ortho Vision / Ortho Clinical Diagnostics automated immunohematology systems
- Bio-Rad IH-1000 / IH-500 and related gel/column systems
- Grifols Erytra / Wadiana automated blood typing systems
- Immucor NEO / Echo luminescent immunohematology systems
- Manual tube testing with centrifugation and macroscopic reading
- Column agglutination (gel/bead) card systems
- Solid-phase red cell adherence platforms
Manual methods
- Manual tube testing with immediate-spin and AHG phases as applicable
Reference Values
Immunohematology interpretations follow institutional SOPs aligned with AABB Standards, ISBT terminology, and applicable CLSI / BSH guidance. Reagent lots, method (tube, gel, solid-phase), and patient history critically affect results; always verify against the performing laboratory’s current procedure and applicable standards edition.
Expected: negative (no unexpected antibodies detected). Positive screens require identification before elective antigen-negative unit selection.
Interpretation
Critical blood bank findings (e.g., ABO discrepancy blocking issue, positive crossmatch when blood is needed urgently, acute hemolytic transfusion reaction workup) follow institutional urgent-notification pathways. Confirm the local call list.
Critical values
- Newly positive screen in a patient needing urgent blood; initiate ID/workup and communication per SOP
Common Causes of Increased Results
- Positive screen; alloantibody, autoantibody, or rouleaux/interference; proceed to identification panel
Common Causes of Decreased Results
- Negative screen; no detectable unexpected antibody by the method; does not detect all antibodies (low titer, low-frequency antigens)
Clinical Significance
- Type and screen / pretransfusion testing
- Prenatal testing panels
Factors Affecting Results
Pre-analytical
- Patient misidentification or unlabeled/mislabeled specimens
- Wrong tube type or clotted EDTA specimen when plasma is required
- Specimen older than institutional pretransfusion dating limits
- IV fluid contamination or draw above an infusion
Analytical
- Omitting AHG or check cells (tube method)
- Failure to detect antibodies to low-frequency antigens absent from screen cells
Post-analytical
- Transcription/LIS mapping errors of ABO/Rh or antibody results
- Issuing products before resolving ABO discrepancies or positive screens per policy
- Incomplete documentation of special requirements (antigen-negative, irradiated, etc.)
Advantages and Limitations
Advantages
- Efficient detection of most clinically significant alloantibodies
Limitations
- Negative screen ≠ absolute absence of all antibodies
- May miss antibodies to antigens not on screening cells
Clinical Pearls
A negative screen is reassurance, not omniscience; low-frequency antigens and low titers still surprise.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- Cohn CS, Delaney M, Johnson ST, Katz LM, eds. Technical Manual. 21st ed. AABB; 2023.
- Fung MK, Eder AF, Spitalnik SL, Westhoff CM, eds. Technical Manual. 20th ed. AABB; 2020.
- Harmening DM. Modern Blood Banking & Transfusion Practices. 7th ed. F.A. Davis; 2019.
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021.
- Bain BJ, Bates I, Laffan MA, eds. Dacie and Lewis Practical Haematology (verify current edition). Blood transfusion chapters.
CLSI and Professional Guidelines
- AABB. Standards for Blood Banks and Transfusion Services (verify current edition and institutional adoption).
- U.S. Food and Drug Administration. Code of Federal Regulations Title 21 . Blood and Blood Components (verify current institutional adoption).
- World Health Organization. Blood safety and availability / transfusion guidance (verify current WHO publication and institutional adoption).
- Clinical and Laboratory Standards Institute. Related immunohematology and specimen identity standards (verify current documents and institutional adoption).
- International Society of Blood Transfusion (ISBT). Blood group terminology and transfusion guidance (verify current ISBT publications).
- British Society for Haematology (BSH). Guidelines for blood grouping, antibody testing, and transfusion practice (verify current BSH guideline editions).
- Clinical and Laboratory Standards Institute. Immunohematology, specimen identification, and related transfusion laboratory documents (verify current CLSI editions).
WHO Publications
- World Health Organization. Blood safety, availability, and clinical transfusion guidance (verify current WHO publication).
Frequently Asked Questions
Common questions about using this Antibody Screen laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Antibody Screen laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of Antibody Screen. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find Antibody Screen specimen requirements?
See the Specimen Requirements section on this page for specimen information related to Antibody Screen. Confirm collection details against your laboratory protocol.
Where are Antibody Screen reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret Antibody Screen results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for Antibody Screen?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from Antibody Screen?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading Antibody Screen?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Blood Bank / Transfusion Medicine topic.
What are the clinical pearls for Antibody Screen?
See the Clinical Pearls section for concise laboratory practice notes associated with Antibody Screen. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.